首页> 外文期刊>Journal of Periodontology >Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases
【24h】

Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases

机译:Odanacatib是组织蛋白酶K特异性抑制剂,可抑制牙周疾病引起的炎症和骨质流失

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Periodontitis is a bacteria-induced inflammatory disease mainly affecting periodontal tissues, leading to periodontal inflammation, bone breakdown, and loss of the tooth. The main obstacle for treating periodontitis effectively is the difficulty in finding a target that can inhibit bone loss and inflammation simultaneously. Recent studies showed that cathepsin K (CTSK) might have functions in the immune system besides its role in osteoclasts. Thus, targeting CTSK would have a potential therapeutic effect in both the bone system and the immune system during the progression of periodontitis.
机译:背景:牙周炎是一种细菌引起的炎症性疾病,主要影响牙周组织,导致牙周炎症,骨骼破裂和牙齿脱落。有效治疗牙周炎的主要障碍是难以找到可以同时抑制骨丢失和炎症的靶标。最近的研究表明,组织蛋白酶K(CTSK)除了在破骨细胞中的作用外,还可能在免疫系统中起作用。因此,在牙周炎发展过程中,靶向CTSK对骨骼系统和免疫系统都有潜在的治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号